Berry Anderson to Treatment Outcome
This is a "connection" page, showing publications Berry Anderson has written about Treatment Outcome.
Connection Strength
0.139
-
Brain stimulation therapies for mood disorders: the continued necessity of electroconvulsive therapy. J Am Psychiatr Nurses Assoc. 2011 May-Jun; 17(3):214-6.
Score: 0.041
-
Decreasing procedural pain over time of left prefrontal rTMS for depression: initial results from the open-label phase of a multi-site trial (OPT-TMS). Brain Stimul. 2009 Apr; 2(2):88-92.
Score: 0.036
-
Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment-resistant depression. Depress Anxiety. 2011 Nov; 28(11):973-80.
Score: 0.011
-
Safety, tolerability, and effectiveness of high doses of adjunctive daily left prefrontal repetitive transcranial magnetic stimulation for treatment-resistant depression in a clinical setting. J ECT. 2011 Mar; 27(1):18-25.
Score: 0.010
-
Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry. 2010 May; 67(5):507-16.
Score: 0.010
-
Bilateral epidural prefrontal cortical stimulation for treatment-resistant depression. Biol Psychiatry. 2010 Jan 15; 67(2):101-9.
Score: 0.009
-
A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders. Brain Stimul. 2008 Apr; 1(2):112-21.
Score: 0.008
-
A single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophrenia. Schizophr Res. 2007 Jul; 93(1-3):42-50.
Score: 0.008
-
Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: a pilot study of acute safety and efficacy. Bipolar Disord. 2003 Feb; 5(1):40-7.
Score: 0.006